LAS191859 is an orally active, potent and selective CRTh2 antagonist with an IC 50 of 9.58 nM against human CRTh2. LAS191859 can be used for the research of chronic asthma.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Prostaglandin Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.